Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Accent, ago, andworldwide, Blackhawk, Bovine, Brazil, broader, capability, Ciphergen, close, conversion, costly, disease, eliminate, Encephalopathy, es, extended, facilitation, fee, GAAP, Geographically, headcount, issuable, Laser, metrology, mix, Nan, optoelectronic, ot, owed, ownership, paymen, private, privately, ProteinChip, repaid, Russia, semiconductor, Spongiform, Stat, Surface, typically, Union
Filing tables
Filing exhibits
Related press release
BIO similar filings
Filing view
External links
Exhibit 32.2
Certification of Periodic Report
I, Christine A. Tsingos, Chief Financial Officer of Bio-Rad Laboratories, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
(1)
the Quarterly Report on Form 10-Q of the Company for the year ended September 30, 2006 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 8, 2006 |
| /s/ Christine A. Tsingos |
|
| Christine A. Tsingos |
|
| Vice President, |
|
| Chief Financial Officer |